SCIESCOPUSQ2
Biologics-Targets & Therapy
DOVE MEDICAL PRESS LTD, New Zealand
Biologics-Targets & Therapy is an academic journal published by DOVE MEDICAL PRESS LTD (New Zealand). Identifiers: ISSN 1177-5475, eISSN 1177-5491. Indexed in SCIE, SCOPUS. Metrics: JIF 3.4, CiteScore 10.8, SJR 1.612, SNIP 1.27. Subject areas: MEDICINE, RESEARCH & EXPERIMENTAL. tlooto lists 582 papers from this journal.
CiteScore
10.80
Scopus citation metric
SJR
1.612
SCImago rank
SNIP
1.27
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- 1177-5475
- eISSN
- 1177-5491
- Abbreviation
- BIOL-TARGETS THER
- Publisher
- DOVE MEDICAL PRESS LTD
- Country
- New Zealand
Web of Science categories
No Web of Science category data available.
Scopus ASJC categories
2715 Gastroenterology2723 Immunology and Allergy2730 Oncology2736 Pharmacology (medical)2745 Rheumatology
Papers in this journal
Recent papers
- Net Present Value Impact of FDA’s Phase 3 Waivers on Monoclonal Antibody Biosimilar Development
2026
- Research on the Role of Autophagy in Vascular Endothelial Cells in the Healing of Chronic Refractory Wounds
2026
- Teclistamab for Relapsed or Refractory Multiple Myeloma: A Review of Efficacy, Safety, Resistance Mechanisms and Future Directions
2026 · 1 citations
- Rheumatoid Factor Beyond Rheumatoid Arthritis: A Potential Marker of Cardiometabolic and Hepatic Risk
2026
- Vunakizumab and Acitretin for Elderly Refractory Generalized Pustular Psoriasis: A Case Report and Comprehensive Literature Review
2026
Most cited papers
- Subcutaneous immunoglobulin therapy: a new option for patients with primary immunodeficiency diseases
2012 · 412 citations
- Mechanism and Applications of CRISPR/ Cas-9-Mediated Genome Editing
2021 · 314 citations
- Gaucher disease: clinical profile and therapeutic developments
2010 · 306 citations
- The molecular profile of luminal B breast cancer
2012 · 216 citations
- Cervarix™: a vaccine for the prevention of HPV 16, 18-associated cervical cancer
2008 · 185 citations